Silver Book Fact

Gains in healthy years of life and social value from cancer R&D

Fact image

Lakdawala D, Sun E, Jena A, Reyes C, et al. An Economic Evaluation of the War on Cancer. J Health Econ. 2010; 29(3): 333-46. http://www.sciencedirect.com/science/article/B6V8K-4YH567G-1/2/88c88fbdd7f57d9fe08803ec85397bc0

Reference

Title
An Economic Evaluation of the War on Cancer
Publication
J Health Econ
Publication Date
2010
Authors
Lakdawala D, Sun E, Jena A, Reyes C, et al.
Volume & Issue
Volume 29, Issue 3
Pages
333-46
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value
  • Economic Value

Related Facts

  • Medicines Prevent Cancer Recurrence: New breast cancer drug greatly reduces recurrence and death (5 to 10 years after diagnosis in postmenopausal women)  
  • In the U.S., new cancer drugs have increased life expectancy at birth by 10.7%.  
  • A drug that can reduce the risk of breast cancer in high-risk women costs approximately $1,050 per year. The average cost per year for surgery or other invasive methods of…  
  • The 5-year survival rate for all cancers diagnosed between 1995 and 2001 is up from 50% in 1974-1976 to 65%.  
  • According to the Pharmaceutical Research and Manufacturers of America, a medicine in development targets CA125, a surface protein, or antigen, that is released in excess quantities by some ovarian cancers.…